Commercially available enzyme immunoassays (EIAs) were used for oestro
gen (ER) and progesterone (PR) receptor determination in the cytosol f
raction of 118 human larynx cancer specimens and in the corresponding
histologically proven non-malignant tissues. Fifty-one ER positive can
cerous samples had corresponding non-cancerous tissues also expressing
the receptor. A high resolution isoelectric focusing (IEF) technique
followed by immunoblotting with the H222 anti-ER monoclonal antibody w
as used to evaluate the presence of ER isoforms in the 51 ER positive
human larynx cancer specimens and in their corresponding non-malignant
tissues. In both tissues, four ER isoforms were detected, with isoele
ctric points (pl) similar to those obtained in breast and endometrium
carcinomas (6.1, 6.3, 6.6 and 6.8). A significant difference in the ex
pression of ER isoforms between cancerous and non-cancerous tissues wa
s found; precisely, the 94.1% of the ER positive nonmalignant specimen
s co-expressed the four,isoforms, while they were detected in only the
35.3% of the malignant specimens (P < 0.0001 by Fisher's exact test).
In larynx cancer, the concentration values of ER and PR did not corre
late, nevertheless tumours co-expressing the four ER isoforms had PR l
evels significantly higher than those which did not (P = 0.02 by Mann-
Whitney-Wilcoxon sum rank test). To investigate the possibility that t
he isoforms of the monomeric 4S form of the ER (those with pl 6.3, 6.6
and 6.8) could dimerise, a cold agarose gel electrophoresis technique
was used on IEF-separated ER isoforms. In summary, the evidence shows
that all the isoforms are able to form homodimers and that the isofor
ms at pi 6.3 and 6.8 are able to dimerise with that at pl 6.6 but, und
er the same experimental conditions, they do not form the 6.3/6.8 hete
rodimer. It was concluded that: (1) the four isoforms of the ER are co
-expressed by the non-malignant human larynx and the cancer loses the
capacity to express some of them; (2) the complete complement of ER is
oforms (all four) is needed for PR expression; (3) the monomeric 4S is
oform with pi 6.6 has the capacity to form homo- and heterodimers, whi
le the remaining two are only able to homodimerise.